System Transmission

Top Signal

100#1 JOB

Activity

2164Ripe

+920 today

System

Livenow

Terminal Asset View

stockNASDAQ

SKYE

$0.66-6.61%

Skye Bioscience Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

21Overripe

Live Analysis Active

Company Mission

Skye Bioscience develops treatments for eye diseases using cannabinoid-based science. They create experimental drugs that target conditions like glaucoma and retinal diseases. The company makes money through research partnerships with other pharmaceutical companies and by advancing their drug candidates through clinical trials toward potential FDA approval and future sales.

SKY

Industry Context

Skye operates in the biotechnology sector, which focuses on developing new medical treatments through scientific research. This industry is highly speculative with companies spending years in research before potentially bringing products to market.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

80Matrix

Market Momentum

35.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-6.61%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing SKYE across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:59 AM UTC

As-of 03-15-2026 06:43 UTC

Develops eye disease treatments using cannabinoid science and makes money by licensing its drug discoveries to pharmaceutical companies.

Price below key moving averages, suggesting a downtrend that could continue if support levels aren't found.

Technical squeeze detected near current levels, indicating potential for a breakout move when volatility expands, suggesting volatility expands.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...